[GLOS85_code]

Strategic Management and Compliance for Research and Experimental (R&E) Expenditures Under U.S. Tax Law

Section 1: Executive Summary and Defining the Research and Experimental Nexus

1.1 Meaning and Context of R&E Expenditures (IRC §174)

Research and Experimental (R&E) Expenditures, as fundamentally defined under Internal Revenue Code (IRC) Section 174, represent costs incurred in connection with a taxpayer’s trade or business that qualify as research and development in the “experimental or laboratory sense”.1 The scope of these expenditures is exceptionally broad, encompassing all costs incident to the development or improvement of a product, process, formula, invention, computer software, or technique.2 Included costs are extensive, ranging from direct employee salaries, laboratory materials, heat, light, and power, to less obvious costs like depreciation on buildings attributable to the R&E project, and even attorneys’ fees incurred for obtaining a patent.1 A critical statutory provision, IRC Section 174(c), mandates that any amount paid or incurred in connection with the development of any software must be treated as a research or experimental expenditure.3 This comprehensive definition ensures that nearly all costs associated with development activities must be tracked and classified under this section.

The significance of R&E expenditures was fundamentally altered by the Tax Cuts and Jobs Act (TCJA) of 2017. For taxable years beginning after December 31, 2021, these costs are no longer immediately deductible in the year they are incurred. Instead, taxpayers are required to capitalize these expenditures and amortize them over a specified period.3 Specifically, domestic R&E expenditures must be amortized ratably over 60 months (five years), while R&E expenditures conducted outside the United States must be amortized over 180 months (fifteen years).4 This mandatory capitalization rule has resulted in a massive shift in corporate tax planning, transforming what was once a powerful current-year tax deduction into a long-term capitalized asset, invariably increasing current-year taxable income for development-heavy businesses.5

1.2 Importance and the R&D Tax Credit Link (IRC §41)

R&E expenditures hold a pivotal importance within U.S. tax compliance because they govern both the mandatory financial reporting treatment under Section 174 and the eligibility for the incremental Research and Development (R&D) Tax Credit under IRC Section 41.6 Eligibility under Section 174 acts as the foundational gateway—often referred to as the Section 174A test—that an expense must pass before it can even be considered a Qualified Research Expense (QRE) eligible for the Section 41 credit.7 This dual role creates significant compliance complexity, as Section 174 is broad (determining the capitalization basis), while Section 41 imposes much stricter qualification criteria designed to target truly incremental research efforts aimed at discovering technological information and eliminating uncertainty.8

The mandatory capitalization requirement under Section 174 introduces substantial complexities that extend beyond simple tax calculation. The capitalization mandate reduces current-year deductions, which in turn elevates Adjusted Taxable Income (ATI), consequently impacting the limitation on interest expense deductions under Section 163(j).9 Furthermore, the requirement to track and manage two distinct categories of R&E expenses—the broad, capitalized base of Section 174, and the narrow, credit-eligible QRE base of Section 41—requires sophisticated cost accounting systems. To avoid claiming a double tax benefit (the amortization deduction plus the credit), taxpayers must utilize IRC Section 280C(c), which requires either the reduction of the R&D credit taken or a reduction in the capitalized basis of the R&E expenditures.7 This foundational compliance mechanism links the capitalization rules directly to the economic benefit derived from the R&D credit itself.

Section 2: Technical Deep Dive: Defining the Scope of R&E Expenditures (IRC §174)

2.1 The Definition of “Experimental or Laboratory Sense”

The Treasury Regulations define R&E costs as those incident to the development or improvement of a business component, focusing on the activity’s nature as “experimental or laboratory”.1 This is designed to capture the costs of activities where technological uncertainty exists, but it is applied more broadly for capitalization purposes than the subsequent test for the R&D credit. A major change introduced by the TCJA was the removal of the requirement that an R&E cost must be “reasonable under the circumstances”.2 While prior regulations generally deemed an amount reasonable if it would ordinarily be paid for like activities by like enterprises, the removal of this filter has broadened the universe of expenses subject to Section 174.

The elimination of the reasonableness test signifies that tax professionals can no longer exclude high-cost expenditures simply by arguing they are excessive or imprudent.2 The focus for compliance shifts entirely to proving the activity’s nature—that it is conducted in an experimental or laboratory sense—rather than assessing the cost’s amount. This regulatory change has the effect of increasing the initial capitalizable basis for many companies, particularly those involved in large-scale, high-cost development projects. Consequently, there is an increased burden on internal controls and accounting teams to accurately classify the activities themselves to ensure full compliance with the mandatory capitalization requirement.

2.2 Key Cost Components and Inclusions

Section 174 compliance requires the meticulous tracking and inclusion of various cost categories incident to the research activity. The primary inclusion is the cost of salaries and wages for personnel conducting or directly supervising the research.2 However, the scope extends significantly beyond direct labor. Costs incident to the R&E include indirect and overhead expenses such as heat, light, power, drawings, models, and laboratory materials.2 Additionally, the capitalized basis includes costs associated with obtaining legal protection for the research, such as attorneys’ fees for securing patents.1 Depreciation on buildings and equipment directly attributable to the R&E project must also be capitalized under Section 174.2

Perhaps the most economically disruptive component is the mandatory inclusion of all software development costs. The statute explicitly requires that any amount paid or incurred in connection with the development of any software shall be treated as an R&E expenditure.3 For technology and software companies, where a vast majority of operational expenses consist of salaries paid to developers, this inclusion is monumental. Shifting these salary-heavy expenses from an immediate tax deduction to a 5-year amortization schedule has exerted significant upward pressure on the taxable income of these firms, potentially damaging cash flow and diverting capital that might otherwise fund further domestic research investment. This direct cause-and-effect relationship between the statute and corporate financial health illustrates the profound impact of the Section 174 capitalization mandate on the high-tech sector.

2.3 Exclusions and Areas of Ambiguity

While the definition is expansive, certain expenditures are explicitly excluded from Section 174 capitalization. Specifically, the statute does not apply to any expenditure paid or incurred for the purpose of ascertaining the existence, location, extent, or quality of any deposit of ore or other mineral, including oil and gas.3 This exclusion keeps mineral exploration costs separate from R&E capitalization rules.

Despite the comprehensive nature of the regulations, recent IRS guidance, such as Notice 2023-63, has highlighted several critical areas requiring further regulatory clarity.4 The IRS has indicated that forthcoming proposed regulations will address detailed definitions of specific software development costs and provide special rules for determining what activities related to developing a website constitute software development.10 Furthermore, substantial ambiguity persists regarding the treatment of research performed under contract. Rules are needed to definitively determine which party to the research contract—the payor or the performer—is considered to have incurred the R&E expenditures under Section 174.10 Establishing the clear incidence of the expenditure is crucial for accurate capitalization and amortization reporting.

Section 3: The Interplay: R&E Capitalization (§174) as the R&D Credit Gateway (§41)

3.1 The Section 174A Test as the Prerequisite

For a business to leverage the R&D tax credit, an expense must first pass the Section 174A test, meaning the expense must be eligible for deduction or capitalization under Section 174.7 This makes Section 174 the non-negotiable starting point for the subsequent credit analysis under Section 41.6 Importantly, Section 41 imposes additional geographic restrictions. While foreign R&E expenditures must be capitalized and amortized over 15 years under Section 174, they are generally not eligible to be considered Qualified Research Expenses (QREs) for the Section 41 credit, which requires research activities to be conducted within the United States.7

3.2 The Four-Part Test for Qualified Research Expenses (QREs)

To bridge the gap between a capitalizable R&E expenditure and an R&D credit-eligible QRE, the expense must meet the stringent “Four-Part Test” outlined in Section 41.7 These tests ensure that the credit is narrowly applied to technological innovation rather than routine development.

1. Section 174A Test: As established, the expense must be eligible for capitalization under Section 174.7
2. Technological Information Test: The research must aim to eliminate uncertainty concerning the capability, method, or design of a business component.
3. Technological in Nature: The process used to discover the information must rely on the principles of the physical or biological sciences, engineering, or computer sciences.8 This excludes activities primarily relying on social sciences or market analysis.
4. Process of Experimentation: The taxpayer must demonstrate a systematic trial-and-error process, involving activities such as ongoing testing, modeling, simulation, or systematic trial and error, used to evaluate alternatives to achieve the desired result.8

3.3 Managing the IRC §280C(c) Election

The intersection of Section 174 and Section 41 is governed by IRC Section 280C(c), a mandatory constraint designed to prevent taxpayers from receiving a double tax benefit on the same dollar of research spending.7 The provision requires that the R&E expenditure deduction (now amortization) be reduced by the amount of the R&D credit taken, unless the taxpayer elects to reduce the credit itself.7

With R&E expenditures now subject to mandatory capitalization and amortization, the decision concerning the Section 280C(c) election carries long-term financial implications. When R&E was immediately deductible, the choice was a simple current-year calculation. Now, a taxpayer who chooses to reduce the capitalized basis of the R&E asset effectively reduces the future stream of amortization deductions over the subsequent 5 or 15 years.4 This complexity necessitates advanced financial modeling, typically involving Net Present Value (NPV) analysis, to determine whether reducing the credit or reducing the capitalized basis yields the greater economic advantage over the amortization period. This requirement for forward-looking analysis ensures consistency between the tax return and financial reporting under ASC 740, particularly regarding Deferred Tax Assets (DTAs).5

Table 1: Comparison of IRC §174 (R&E Basis) and IRC §41 (QRE Credit)

Section 4: Mandatory Capitalization: Mechanics and Cross-Cutting Tax Implications

4.1 The Amortization Mechanics and Method Change

The mandatory capitalization requirement applies to all R&E expenditures paid or incurred in taxable years beginning after December 31, 2021.3 Implementing this change constitutes a mandatory change in the taxpayer’s method of accounting. Critically, this change is applied on a cut-off basis, meaning the taxpayer simply begins applying the new rules prospectively, and no adjustments under Section 481(a) are required for expenditures paid or incurred in prior years.3

The amortization schedule follows a specific timeline: domestic R&E expenditures are amortized over 60 months, and foreign R&E expenditures over 180 months. Regardless of when the expenditure occurs during the year, the amortization period begins at the midpoint of the taxable year in which the R&E expenditures are paid or incurred.4 For short taxable years, the amortization deduction is calculated based on the number of months in the short taxable year, commencing from the midpoint.4

4.2 The Anti-Abuse Rule: Section 174(d) Dispositions

A critical and potentially punitive provision is found in IRC Section 174(d), which addresses the treatment of capitalized R&E upon disposition or abandonment of the related property. This section explicitly provides that if any property related to the capitalized R&E expenditures is disposed, retired, or abandoned during the amortization period, no deduction shall be allowed for the unamortized balance on account of the disposition, retirement, or abandonment.4

This rule constitutes a significant deviation from general tax principles, which typically allow for the recognition of a loss upon the disposal or worthlessness of an asset. Instead, the taxpayer is required to continue amortizing the remaining capitalized R&E balance over the original 5- or 15-year statutory period.4 This structure creates a permanent tax drag where the capitalized basis of a failed project—for example, a software platform that is scrapped two years into development—must still be amortized against the taxpayer’s future income for the remaining three years, regardless of its economic uselessness. Taxpayers must implement robust tracking mechanisms to manage these “dead” assets to ensure continued amortization compliance.

4.3 Broader Intersectional Tax Consequences

The mandatory capitalization of R&E expenditures sends ripples across several complex corporate tax regimes.9

The calculation of the Interest Expense Limitation under Section 163(j) is directly impacted because the R&E capitalization reduces current deductions, thereby increasing a taxpayer’s Adjusted Taxable Income (ATI), which is the base against which the limitation is applied.9 This increase in ATI may, counterintuitively, allow a taxpayer to deduct a greater amount of interest expense.

In the international arena, the capitalization rule profoundly affects calculations related to the Foreign-Derived Intangible Income (FDII) and Global Intangible Low-Taxed Income (GILTI) regimes.9 R&E expenses are crucial inputs for determining income and loss allocations in these complex formulas. Capitalizing these costs, especially foreign R&E over 15 years, fundamentally alters the distribution of taxable income between foreign and domestic jurisdictions. For multinational enterprises (MNEs), this change compels a complete re-engineering of global tax compliance and forecasting models to account for this single statutory amendment. This represents a significant destabilization of complex international tax planning.

Furthermore, state and local tax (SALT) compliance is complicated by the fact that many states have not conformed to the federal Section 174 capitalization rules.9 This non-conformity requires taxpayers to maintain dual sets of R&E calculations, necessitating immediate expensing for state purposes while capitalizing for federal purposes, further increasing administrative and compliance burdens.

Table 2: Mandatory Amortization Schedule and Disposition Rules

Section 5: Practical Application and Documentation Requirements

5.1 Concrete Example: Capitalization and Credit Eligibility in Software Development

Consider a U.S.-based manufacturing company that develops new proprietary software intended to optimize its supply chain logistics. During the first year, the company incurs $5 million in domestic R&E expenditures, primarily consisting of salaries for the development team, cloud computing services, and professional fees.2

Under Section 174, this entire $5 million must be capitalized and amortized over five years, commencing at the midpoint of the year, regardless of the ultimate success of the project.3 This capitalized basis represents the full cost incident to the development.2

However, when evaluating the costs for the R&D credit under Section 41, the company determines that only $3 million of the total R&E costs meet the strict Four-Part Test. This $3 million subset relates specifically to designing novel optimization algorithms that required systematic trial-and-error to eliminate technological uncertainty regarding performance.7 The remaining $2 million, covering routine coding, maintenance, and user interface design, is capitalizable under §174 but does not qualify as a QRE under §41.6

If the resulting R&D credit based on the $3 million QREs is $300,000, the company must address the Section 280C(c) constraint.7 The company must model whether it is more advantageous to reduce the capitalized Section 174 basis from $5 million to $4.7 million (reducing future amortization deductions) or to reduce the R&D credit taken by the required amount. This highlights the practical difference between the expansive capitalization scope of Section 174 and the focused credit eligibility of Section 41.

5.2 IRS Documentation and Substantiation Requirements

The IRS maintains stringent documentation requirements for R&E expenditures, necessary for substantiating both the capitalized basis and the qualified research credit.12 Taxpayers are required to retain records in a sufficiently usable form and detail to substantiate that the expenditures claimed are eligible.12 Examples of essential records include employee Form W2s, payroll registers, time tracking data detailing specific research activities, invoices for qualified supplies, technical design requirements, test plans, and results.12

For claims filed for the R&D tax credit, the IRS has significantly heightened its expectations, particularly regarding substantiation requirements outlined in updates concerning Form 6765.5 To file a valid research credit claim, taxpayers must provide specific elements, including:

• Identification of all business components to which the credit relates.13
• A description of research activities performed for each component, demonstrating the systematic process.13
• The total qualified employee wage, supply, and contract research expenses.13

While the IRS has recently waived the requirement to provide the names of individuals and the specific information sought at the time a refund claim is filed, maintaining this granular data internally remains absolutely essential for surviving a subsequent audit.13 The heightened scrutiny mandates a comprehensive approach to data collection that aligns tax, finance, and R&D functions.5

Section 6: Next Steps: Achieving Full Utilization and Mitigating Audit Risk

To navigate the complex compliance landscape created by the dual mandates of Section 174 capitalization and Section 41 credit eligibility, corporate tax departments and finance leadership must move beyond reactive compliance toward proactive, strategic process overhaul.

6.1 Process Overhaul and Data Integration

1. Implement Integrated R&D Tracking Systems: An immediate overhaul of accounting processes is required to align three distinct data streams: financial reporting (book depreciation), the capitalized tax basis under Section 174, and the credit-eligible QREs under Section 41.5 Automation tools and centralized data systems should be prioritized to ensure consistent expense tracking and minimize audit risk.5
2. Enforce Granular Time Tracking and Allocation: Mandate time tracking systems that allocate employee hours to the specific business component level. These systems must differentiate between activities that qualify for the strict R&D credit criteria (technological uncertainty, experimentation) and those that are merely subject to Section 174 capitalization (e.g., routine maintenance, management overhead).5
3. Centralize Documentation Repository: Establish a robust, easily accessible digital repository for all supporting R&E documentation—including technical specifications, prototype documents, and formal test results—to readily substantiate both the capitalized asset and the credit claim upon IRS inquiry.13

6.2 Strategic Management of Capitalization and Cross-Border Issues

1. Optimize the §280C(c) Election Annually: Given that R&E is now amortized over multiple years, annual financial modeling must be conducted to optimize the net benefit derived from the Section 280C(c) election. This modeling requires comparing the present value of reducing the capitalized basis (and thus reducing future deductions) against the present value of reducing the current-year R&D credit.5
2. Address Foreign R&E Allocation Rigorously: Meticulous segregation of domestic R&E (5-year amortization) from foreign R&E (15-year amortization) is essential.4 This segregation directly impacts international tax compliance, including the correct allocation of expenses for GILTI and FDII purposes, requiring close collaboration between international tax teams and R&D project managers.9

6.3 Seeking Prospective Clarity and Legislative Monitoring

1. Formalize Policies Based on IRS Guidance: Utilize the clarifications provided by IRS guidance, such as Notice 2023-63, to establish formal, written policies on complex issues including the treatment of research performed under contract and the required continued amortization for abandoned assets under Section 174(d).4 This proactive codification mitigates future audit exposure.
2. Maintain Contingency Plans for Legislative Changes: Significant legislative pressure exists to reverse the mandatory capitalization of domestic R&E.11 Therefore, compliance systems must be flexible. Because the political landscape remains unstable, tracking procedures should be designed to allow for a seamless and accurate transition back to immediate expensing, should Congress act. This includes the ability to easily calculate and elect accelerated expensing of the remaining capitalized balances from 2022 through 2024, if such a mechanism is provided in future legislation.14 This forward-looking approach to data management is essential for mitigating the regulatory risk inherent in a highly contested tax provision.

Section 7: Conclusion: Strategic Outlook on R&E Management

The imposition of mandatory R&E expenditure capitalization under IRC Section 174 represents a seismic shift in corporate tax planning, moving R&D spending from a strategic cost deduction to a mandatory capitalized asset that significantly increases current taxable income. The central compliance challenge lies in effectively managing the distinction between the broadly defined, capitalized R&E costs (§174) and the narrowly defined, credit-eligible Qualified Research Expenses (§41).

Successful navigation of this new era demands an integrated, process-oriented strategy that enforces granular data capture, leverages technology for compliance automation, and engages in sophisticated financial modeling (e.g., for the Section 280C(c) election). Given the persistence of legislative efforts to reverse the capitalization mandate, tax departments must also prioritize flexibility and contingency planning. The ability to substantiate, allocate, and potentially re-expense the capitalizable R&E costs will determine a company’s success in maximizing the R&D credit while effectively mitigating the heightened financial burdens and audit risks associated with the new amortization regime.5

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/